UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 902

Sortiert nach

LuCaP Prostate Cancer Patient‐Derived Xenografts Reflect the Molecular Heterogeneity of Advanced Disease and Serve as Models for Evaluating Cancer Therapeutics

The Prostate, 2017-05, Vol.77 (6), p.654-671

2017

Link zum Volltext

Verfügbarkeit prüfen

SRRM4 Expression and the Loss of REST Activity May Promote the Emergence of the Neuroendocrine Phenotype in Castration-Resistant Prostate Cancer

Clinical cancer research, 2015-10, Vol.21 (20), p.4698-4708

2015

Link zum Volltext

Verfügbarkeit prüfen

Exome sequencing identifies a spectrum of mutation frequencies in advanced and lethal prostate cancers

Proceedings of the National Academy of Sciences - PNAS, 2011-10, Vol.108 (41), p.17087-17092

2011

Link zum Volltext

Verfügbarkeit prüfen

Disseminated Tumor Cells in Prostate Cancer Patients after Radical Prostatectomy and without Evidence of Disease Predicts Biochemical Recurrence

Clinical cancer research, 2009-01, Vol.15 (2), p.677-683

2009

Link zum Volltext

Verfügbarkeit prüfen

Epithelial mesenchymal-like transition occurs in a subset of cells in castration resistant prostate cancer bone metastases

Clinical & experimental metastasis, 2016-03, Vol.33 (3), p.239-248

2016

Link zum Volltext

Verfügbarkeit prüfen

Chemotherapy-induced monoamine oxidase expression in prostate carcinoma functions as a cytoprotective resistance enzyme and associates with clinical outcomes

PloS one, 2014-09, Vol.9 (9), p.e104271

2014

Link zum Volltext

Verfügbarkeit prüfen

Characterization of osteoblastic and osteolytic proteins in prostate cancer bone metastases

The Prostate, 2013-06, Vol.73 (9), p.932-940

2013

Link zum Volltext

Verfügbarkeit prüfen

Substantial interindividual and limited intraindividual genomic diversity among tumors from men with metastatic prostate cancer

Nature medicine, 2016-04, Vol.22 (4), p.369-378

2016

Link zum Volltext

Verfügbarkeit prüfen

Tertiary Gleason pattern 5 in Gleason 7 prostate cancer predicts pathological stage and biochemical recurrence

The Journal of urology, 2008-05, Vol.179 (5), p.1775

2008

Link zum Volltext

Verfügbarkeit prüfen

Molecular Alterations in Prostate Carcinomas that Associate with In vivo Exposure to Chemotherapy: Identification of a Cytoprotective Mechanism Involving Growth Differentiation Factor 15

Clinical cancer research, 2007-10, Vol.13 (19), p.5825-5833

2007

Link zum Volltext

Verfügbarkeit prüfen

Re: Intermittent Androgen Deprivation (IAD) in Prostate Cancer (PC): Are We Ready To Quit?

European urology, 2016-09, Vol.70 (3), p.542-543

Lange, Paul H

2016

Link zum Volltext

Verfügbarkeit prüfen

PSA screening, prostate biopsy, and treatment of prostate cancer in the years surrounding the USPSTF recommendation against prostate cancer screening

Cancer, 2018-07, Vol.124 (13), p.2733-2739

2018

Link zum Volltext

Verfügbarkeit prüfen

Single cell transcriptomic analysis of prostate cancer cells

BMC molecular biology, 2013-02, Vol.14 (1), p.6-6, Article 6

2013

Link zum Volltext

Verfügbarkeit prüfen

Screening Men at Increased Risk for Prostate Cancer Diagnosis: Model Estimates of Benefits and Harms

Cancer epidemiology, biomarkers & prevention, 2017-02, Vol.26 (2), p.222-227

2017

Link zum Volltext

Verfügbarkeit prüfen

Dormancy in solid tumors: implications for prostate cancer

Cancer and metastasis reviews, 2013-12, Vol.32 (3-4), p.501-509

2013

Link zum Volltext

Verfügbarkeit prüfen

Positive surgical margins at radical prostatectomy predict prostate cancer specific mortality

The Journal of urology, 2010-06, Vol.183 (6), p.2213

2010

Link zum Volltext

Verfügbarkeit prüfen

Serum Osteoprotegerin Levels Are Increased in Patients with Advanced Prostate Cancer

Clinical cancer research, 2001-10, Vol.7 (10), p.2977-2983

2001

Link zum Volltext

Verfügbarkeit prüfen

The biology and clinical implications of prostate cancer dormancy and metastasis

Journal of Molecular Medicine, 2016-03, Vol.94 (3), p.259-265

2016

Link zum Volltext

Verfügbarkeit prüfen

A history of the Society of Urologic Oncology

Urologic oncology, 2021-09, Vol.39 (9), p.514-520

2021

Link zum Volltext

Verfügbarkeit prüfen

Systemic therapy and the urologic oncologist: A unique opportunity for the specialty to provide comprehensive care that ultimately benefits the patient

Urologic oncology, 2012-07, Vol.30 (4), p.S2-S4

2012

Link zum Volltext

Verfügbarkeit prüfen

Re: Does Salvage Radiation Therapy Change the Biology of Recurrent Prostate Cancer Based on PSA Doubling Times? Results from the SEARCH Database

European urology, 2013-02, Vol.63 (2), p.402-403

Lange, Paul H

2013

Link zum Volltext

Verfügbarkeit prüfen

Characterizing the molecular features of ERG-positive tumors in primary and castration resistant prostate cancer

The Prostate, 2016-06, Vol.76 (9), p.810-822

2016

Link zum Volltext

Verfügbarkeit prüfen

Effects of androgen deprivation therapy and bisphosphonate treatment on bone in patients with metastatic castration‐resistant prostate cancer: Results from the University of Washington Rapid Autopsy Series

Journal of bone and mineral research, 2013-02, Vol.28 (2), p.333-340

2013

Link zum Volltext

Verfügbarkeit prüfen

Two-year outcome of unilateral sural nerve interposition graft after radical prostatectomy

Urology (Ridgewood, N.J.), 2006-12, Vol.68 (6), p.1290-1294

2006

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 902

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(841)
Mit Volltextzugriff
(723)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(549)
Life Sciences & Biomedicine
(447)
Humans
(436)
Male
(318)
Biological And Medical Sciences
(199)
Medical Sciences
(174)
Middle Aged
(160)
Female
(151)
Urology & Nephrology
(130)
Aged
(125)
Adult
(118)
Oncology
(86)
Physical Sciences
(74)
Animals
(73)
Prostatic Neoplasms - Pathology
(62)
Nephrology. Urinary Tract Diseases
(60)
Physics Of Elementary Particles And Fields
(55)
Tumors
(47)
Tumors Of The Urinary System
(46)
Physics
(45)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Physical Review. D
(74)
The Journal Of Urology
(66)
Urology
(56)
Physical Review Letters
(23)
Cancer
(21)
Cancer Research
(21)
The New England Journal Of Medicine
(21)
Journal Of The National Comprehensive Cancer Network
(18)
Urologic Clinics Of North America
(15)
Physical Review D
(12)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(8)

Menü

Weitere Dienste

Einstellungen

LuCaP Prostate Cancer Patient‐Derived Xenografts Reflect the Molecular Heterogeneity of Advanced Disease and Serve as Models for Evaluating Cancer Therapeutics

SRRM4 Expression and the Loss of REST Activity May Promote the Emergence of the Neuroendocrine Phenotype in Castration-Resistant Prostate Cancer

Exome sequencing identifies a spectrum of mutation frequencies in advanced and lethal prostate cancers

Disseminated Tumor Cells in Prostate Cancer Patients after Radical Prostatectomy and without Evidence of Disease Predicts Biochemical Recurrence

Epithelial mesenchymal-like transition occurs in a subset of cells in castration resistant prostate cancer bone metastases

Chemotherapy-induced monoamine oxidase expression in prostate carcinoma functions as a cytoprotective resistance enzyme and associates with clinical outcomes

Characterization of osteoblastic and osteolytic proteins in prostate cancer bone metastases

Substantial interindividual and limited intraindividual genomic diversity among tumors from men with metastatic prostate cancer

Tertiary Gleason pattern 5 in Gleason 7 prostate cancer predicts pathological stage and biochemical recurrence

Molecular Alterations in Prostate Carcinomas that Associate with In vivo Exposure to Chemotherapy: Identification of a Cytoprotective Mechanism Involving Growth Differentiation Factor 15

Re: Intermittent Androgen Deprivation (IAD) in Prostate Cancer (PC): Are We Ready To Quit?

PSA screening, prostate biopsy, and treatment of prostate cancer in the years surrounding the USPSTF recommendation against prostate cancer screening

Eligibility and Outcomes Reporting Guidelines for Clinical Trials for Patients in the State of a Rising Prostate-Specific Antigen: Recommendations From the Prostate-Specific Antigen Working Group

Single cell transcriptomic analysis of prostate cancer cells

Screening Men at Increased Risk for Prostate Cancer Diagnosis: Model Estimates of Benefits and Harms

Dormancy in solid tumors: implications for prostate cancer

Positive surgical margins at radical prostatectomy predict prostate cancer specific mortality

Serum Osteoprotegerin Levels Are Increased in Patients with Advanced Prostate Cancer

The biology and clinical implications of prostate cancer dormancy and metastasis

A history of the Society of Urologic Oncology

Systemic therapy and the urologic oncologist: A unique opportunity for the specialty to provide comprehensive care that ultimately benefits the patient

Re: Does Salvage Radiation Therapy Change the Biology of Recurrent Prostate Cancer Based on PSA Doubling Times? Results from the SEARCH Database

Characterizing the molecular features of ERG-positive tumors in primary and castration resistant prostate cancer

Effects of androgen deprivation therapy and bisphosphonate treatment on bone in patients with metastatic castration‐resistant prostate cancer: Results from the University of Washington Rapid Autopsy Series

Two-year outcome of unilateral sural nerve interposition graft after radical prostatectomy

Suchergebnisse filtern